Related Experiment Video
Updated: Apr 6, 2026
09:03
Author Spotlight: Investigating Angiogenesis and Vessel Permeability Through a Modified Matrix Gel Plug Assay
Published on: June 30, 2023
1.9K
Prostanoids regulate angiogenesis acting primarily on IP and EP4 receptors.
Khuyen Gia Hoang1, Sarah Allison2, Michael Murray2
1School of Pharmacy and Medical Sciences, University of South Australia, Australia.
Microvascular Research
|July 20, 2015
Summary
Prostacyclin, not prostaglandin E2, is the main driver of blood vessel formation. The prostacyclin-IP pathway significantly regulates angiogenesis, impacting endothelial cell migration and tube formation.
Area of Science:
- Vascular Biology
- Endocrinology
Background:
- Prostanoids regulate angiogenesis, but their specific roles are unclear.
- Prostaglandin E2 (PGE2) and prostaglandin I2 (prostacyclin/PGI2) are key vascular prostanoids.
- PGE2 activates EP1-4 receptors; prostacyclin activates the IP receptor.
Purpose of the Study:
- Compare the pro-angiogenic roles of PGE2 and prostacyclin.
- Investigate the roles of EP and IP receptors in angiogenesis.
- Determine the impact of prostanoids on endothelial cell function.
Main Methods:
- Used human umbilical vein endothelial cells (HUVECs) for in vitro studies.
- Assessed cell migration using the matrigel droplet assay.
- Evaluated "tube formation" to model blood vessel precursor development.
Main Results:
- IP receptor antagonism (CAY10441) suppressed angiogenesis by ~80%.
- EP4 receptor antagonism (L-161,982) suppressed angiogenesis by ~20%.
- EP and IP receptor agonists showed biphasic dose-dependent effects.
Conclusions:
- The prostacyclin-IP pathway is a major regulator of angiogenesis in HUVECs.
- Prostacyclin plays a more significant role than PGE2 in activating angiogenesis.
- Receptor desensitization influences angiogenic responses to prostanoids.
More Related Videos
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613
01:10Mechanism of Angiogenesis
7.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.7K
01:22PI3K/mTOR/AKT Signaling Pathway
6.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.4K
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.6K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.6K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.9K